首页 | 本学科首页   官方微博 | 高级检索  
     

高灵敏度HBV DNA检测指导慢性乙型肝炎患者抗病毒治疗的临床意义
引用本文:邵国辉,闫香芹,陈合民,张雷,孙敏,孙瑜. 高灵敏度HBV DNA检测指导慢性乙型肝炎患者抗病毒治疗的临床意义[J]. 中华实验和临床感染病杂志(电子版), 2016, 10(1): 46-48. DOI: 10.3877/cma.j.issn.1674-1358.2016.01.010
作者姓名:邵国辉  闫香芹  陈合民  张雷  孙敏  孙瑜
作者单位:1. 272031 济宁市,山东省济宁市传染病医院一病区
基金项目:山东省济宁市科技项目编号(No. 2013jnnk09)
摘    要:目的探讨高灵敏度HBV DNA检测对于指导HBV DNA低载量慢性乙型肝炎(CHB)患者抗病毒治疗的临床意义。 方法收集应用国产试剂检测结果低于检测下限(< 103 IU/ml)的拟停药组112例患者和拟用药组48例患者共160份血清标本采用COBAS Amplicor系统再次进行检测,并与HBsAg定量结果进行对照分析。 结果经国产试剂检测结果低于检测下限(<103 IU/ml)的160份血清经COBAS Amplicor系统再次检测有52例(32.50%)标本HBV DNA > 103 IU/ml,高于高灵敏度HBV DNA检测下限(20 IU/ml)的标本共115份(占71.88%)。拟停药组患者HBV DNA≥ 20 IU/ml者有72例(占64.29%);拟用药组患者中有19例HBV DNA> 103 IU/ml,43例≥ 20 IU/ml(占89.58%)。应用COBAS试剂检测HBV DNA不同载量组别与HBsAg浓度对数值均呈显著正相关(P < 0.01)。 结论对国产试剂检测HBV DNA低载量患者应进一步做高灵敏的定量PCR试剂检测,可更好地指导患者初始应用或停用核苷(酸)类药物。

关 键 词:肝炎病毒  乙型  荧光定量PCR  COBAS Amplicor系统  临床应用  
收稿时间:2015-04-20

The clinical significance of high sensitivity HBV DNA detection for the treatment of antiviral therapy in patients with chronic hepatitis B
Guohui Shao,Xiangqin Yan,Hemin Chen,Lei Zhang,Min Sun,Yu Sun. The clinical significance of high sensitivity HBV DNA detection for the treatment of antiviral therapy in patients with chronic hepatitis B[J]. Chinese Journal of Experimental and Clinical Infectious Diseases(Electronic Version), 2016, 10(1): 46-48. DOI: 10.3877/cma.j.issn.1674-1358.2016.01.010
Authors:Guohui Shao  Xiangqin Yan  Hemin Chen  Lei Zhang  Min Sun  Yu Sun
Affiliation:1. The First Inpatient Area of the Infectious Diseases Hospital of Jining, Shandong Province, Jining 272031, China
Abstract:ObjectiveTo investigate the clinical significance of the high sensitive HBV DNA detection for the antiviral treatment of the chronic hepatitis B (CHB) patients with HBV DNA low viral load. MethodsTotal of 160 sera specimens separated from 112 cases of quasi discontinuation group which were detected lower than the detection line (< 103 IU/ml) and 48 cases of quasi treatment group detected by domestic reagent were tested again using COBAS Amplicor system and compared with the results of quantitative HBsAg. ResultsThere were 52 (32.5%) cases with HBV DNA quantitative value > 103 IU/ml by Amplicor COBAS system out of 160 serum samples lower than the detection line (103 IU/ml) detected by domestic reagent, 115 (71.88%) samples were detected higher than the high sensitive HBV DNA detection line (20 IU/ml). And 72 (64.29%) cases of the withdrawal group were detected than 20 IU/ml; in the treatment group, 19 cases were detected higher than 103 IU/ml, 43 (89.58%) cases were detected ≥ 20 IU/ml in quasi treatment group. There was a significant positive correlation between different HBV DNA load groups by COBAS reagent detection and HBsAg concentration logarithm value (P < 0.01). ConclusionsHigh sensitive quantitative PCR should be furtherly conducted for HBV DNA low load patients to guide the initial application or discontinuation of nucleos(t)ide drugs.
Keywords:Hepatitis B virus  Fluorescence quantitative PCR  COBAS Amplicor system  Clinical application  
本文献已被 CNKI 等数据库收录!
点击此处可从《中华实验和临床感染病杂志(电子版)》浏览原始摘要信息
点击此处可从《中华实验和临床感染病杂志(电子版)》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号